Monday, September 28, 2009

E. coli's Kayak Paddle-Lke Motion Tracked For First Time

E. coli's Kayak Paddle-Lke Motion Tracked For First Time
Yale engineers have for the first time observed and tracked E. coli bacteria moving in a liquid medium with a motion similar to that of a kayak paddle. Their findings, which appear online September 29 in the journal Physical Review Letters, will help lead to a better understanding of how bacteria move from place to place and, potentially, how to keep them from spreading. Scientists have long theorized that the cigar-shaped cell bodies of E.

Sunday, September 27, 2009

Lifestyle Interventions In The Prevention And Treatment Of Cancer

Lifestyle Interventions In The Prevention And Treatment Of Cancer
There is clear evidence that lifestyle choices affect the incidence and treatment of cancer, according to a study published in the current issue of American Journal of Lifestyle Medicine (AJLM).

Friday, September 25, 2009

Sugar-Coating Medicine With Therapeutic Nanoparticles

Sugar-Coating Medicine With Therapeutic Nanoparticles
(NIST) studying sugar-coated nanoparticles for use as a possible cancer therapy has uncovered a delicate balancing act that makes the particles more effective than conventional thinking says they should be. Just like individuals in a crowd respecting other people's personal space, the particles work because they get close together, but not too close.

Historic Gene Therapy Trial To Treat Alzheimer's Disease Underway At Georgetown

Researchers in the Memory Disorders Program at Georgetown University Medical Center are now recruiting volunteers for a national gene therapy trial - the first study of its kind for the treatment of patients with dementia due to Alzheimer's disease. The phase II study examines the safety and possible benefits of CERE-110. CERE-110 contains a gene and is injected during surgery into a part of the brain affected by Alzheimer's disease. Continue reading ...

Thursday, September 24, 2009

World Heart Day, 27 September 2009 - Work With Heart

In the lead up to World Heart Day on 27 September 2009, the World Heart Federation, the World Health Organization and the World Economic Forum have joined forces to call on governments, employers and workers around the world to make workplaces healthier. Over 17.2 million people worldwide die annually from heart disease and stroke - the world's leading cause of death. Continue reading ...

Tuesday, September 22, 2009

Turning Drugs On And Off Using Magnetism

Turning Drugs On And Off Using Magnetism
Many medical conditions, such as chronic pain, cancer and diabetes, require medications that cannot be taken orally, but must be dosed intermittently, on an as-needed basis, over a long period of time. A few delivery techniques have been developed, using an implanted heat source, an implanted electronic chip or other stimuli as an "on-off" switch to release the drugs into the body.

Sunday, September 20, 2009

35,000 Pounds Of Unlicensed Medicine Found In Car Boot

35,000 Pounds Of Unlicensed Medicine Found In Car Boot
More than £35,000 of unlicensed erectile dysfunction medicine was seized in Sutton Coldfield yesterday as part of a covert investigation undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA). A 60-year-old man was arrested for possession with intent to supply the medicines which included Kamagra, Savitra and Apcalis, all unlicensed Indian products.

Saturday, September 19, 2009

Mayo Clinic Researchers Lead National Clinical Trial Testing New Treatment For Chronic, Severe Indigestion

Could medicines used for depression also treat chronic, severe indigestion? Scientists at Mayo Clinic suspect they can and, backed by funding from the National Institutes of Health (NIH), they are testing that premise in a nationwide clinical trial. "Nerve cells are found throughout the body, and just as their dysfunction in the brain can cause depression, we suspect overly sensitive nerves in the gut can produce this very uncomfortable indigestion," says Nicholas Talley, M.D., Ph. More at...

Friday, September 18, 2009

Metabolomics Used To Identify The Mechanism Of Action Of An Anti-Cancer Drug

Metabolomics Used To Identify The Mechanism Of Action Of An Anti-Cancer Drug
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced a new study has been published identifying the mechanism of action of the anti-cancer drug GMX1778. Co-authored by scientists at Gemin X Pharmaceuticals and Metabolon, the paper "The Small Molecule GMX1778 is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in NAPRT1-Deficient Tumors" appears online ahead of print in Molecular and Cellular Biology.

Thursday, September 17, 2009

Increase In CV Risk Factors Heralds Epidemic Of Cardiovascular Disease

Increase In CV Risk Factors Heralds Epidemic Of Cardiovascular Disease
Commenting on a study published today in Circulation (1), showing after two decades of improvement, the percentage of Americans without risk factors for heart disease was falling, Professor Guy De Backer, from the Division of Cardiology at the University of Gent, Belgium, said that with the rising levels of obesity in the US such findings could hardly be considered surprising.

Thursday, September 10, 2009

Dallas Confirms Sixth Human Case Of West Nile Virus

Dallas County Health and Human Services has confirmed the county's sixth human case of West Nile virus for the 2009 season.

Dallas County Health and Human Services has confirmed the county's sixth human case of West Nile virus for the 2009 season.

Source: 
Dallas County Health Department
Complete news at...

Tuesday, September 8, 2009

News From The September Issue Of Chest

PEDIATRIC CHRONIC COUGH LINKED TO REFLUX AND ALLERGIES New research shows that chronic cough in children is most often caused by gastroesophageal reflux and allergies. Researchers from Tulane University in New Orleans, LA, evaluated 40 patients aged 5 to 12 years with chronic cough (> 8 weeks in duration) with no obvious cause. Each patient underwent extensive multispecialty testing. Complete news at...

Monday, September 7, 2009

Tips For Dealing With Fall Allergies From DampRid

For America's 60 million seasonal allergy sufferers, fall can be one of the most difficult times of year as ragweed begins to release its pollen into the air and mold and fungus spores increase due to the decay of leaves and other plants. Each ragweed plant produces one billion pollen grains per average season. This generally continues until the first frost, usually in October. Continue reading ...

Saturday, September 5, 2009

Root Cause Of Alzheimer's Disease Begins To Be Untangled By Scientists

Root Cause Of Alzheimer's Disease Begins To Be Untangled By Scientists
"N60" might not be the first thing that comes to mind when people think of Alzheimer's disease, but thanks to researchers from the United States, South Korea and France, this might change. That's because these researchers have found that the N60 section of a protein called "RanBP9" might be the key that unlocks an entirely new class of Alzheimer's drugs, and with them, hope.

Friday, September 4, 2009

Relapse Of Infections Is The Most Challenging Aspect Of Treating Clostridium Difficile Infections In The Hospital Setting

Arlington Medical Resources (AMR) and Decision Resources find that relapse or recurrence of infections is the most challenging aspect of treating Clostridium difficile infections in the hospital setting. Surveyed infectious disease specialists emphasize the need for new agents that have lower relapse rates than the current standard-of-care. Complete news at...

Thursday, September 3, 2009

Aortic Valve Replacement Indicated For Patients Without Significant Risk

Aortic Valve Replacement Indicated For Patients Without Significant Risk

Patients who have aortic valve replacement (AVR) surgery but did not have other significant risk factors have a nearly identical 30-month survival rate as the general population.

Patients who have aortic valve replacement (AVR) surgery but did not have other significant risk factors have a nearly identical 30-month survival rate as the general population, according to a study

Source: 
University At Albany

Teflon-coated Cells Could Help Treat Type 1 Diabetes

Teflon-coated Cells Could Help Treat Type 1 Diabetes
Scientists have invented a tiny implant covered in Teflon coating that contains transplanted insulin-producing cells. Teflon, the chemical used to coat non-stick pans, has been used in medicine for more than 30 years, as it is compatible with human tissue and does not cause the immune system to attack itself when implanted in the body.

Tuesday, September 1, 2009

NeuroVasx Receives Canadian Approval For CPAX Aneurysm Treatment System

NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009. Eric B. More at...